Fenofibric Acid (Halton Laboratories)
Welcome to the PulseAid listing for the Fenofibric Acid drug offered from Halton Laboratories. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Halton Laboratories |
NON-PROPRIETARY NAME: | Fenofibric Acid |
SUBSTANCE NAME: | FENOFIBRIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-07-30 |
END MARKETING DATE: | 0000-00-00 |
Fenofibric Acid HUMAN PRESCRIPTION DRUG Details:
Item Description | Fenofibric Acid from Halton Laboratories |
LABELER NAME: | Halton Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 35(mg/1) |
START MARKETING DATE: | 2015-07-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69973-035_f38c3067-3e3f-45fe-9dd2-814bc7bd3210 |
PRODUCT NDC: | 69973-035 |
APPLICATION NUMBER: | NDA022418 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers: